CA Stock MarketDetailed Quotes

MDX Medx Health Corp

Watchlist
  • 0.065
  • -0.005-7.14%
15min DelayMarket Closed Jan 3 16:00 ET
17.56MMarket Cap-6.50P/E (TTM)

Medx Health Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-18.56%90.61K
-54.60%104.3K
117.05%106.75K
-10.68%456.09K
-68.83%66.33K
23.37%111.26K
60.69%229.75K
-23.91%49.18K
-9.32%510.61K
0.02%212.81K
Operating revenue
-18.56%90.61K
-54.60%104.3K
117.05%106.75K
-10.68%456.09K
-68.83%66.33K
23.37%111.26K
60.69%229.75K
-23.91%49.18K
-9.32%510.61K
0.02%212.81K
Cost of revenue
23.92%56.53K
-61.82%49.24K
145.42%74.83K
-0.07%270.46K
-29.79%64.25K
-22.54%45.62K
79.83%128.97K
-30.86%30.49K
-6.59%270.66K
40.47%91.51K
Gross profit
-48.08%34.08K
-45.36%55.07K
70.78%31.92K
-22.64%185.63K
-98.28%2.09K
84.49%65.64K
41.42%100.78K
-8.98%18.69K
-12.22%239.95K
-17.83%121.3K
Operating expense
-42.05%521.13K
-10.83%791.37K
-1.23%782.24K
-21.85%3.21M
-42.39%632.05K
-1.16%899.27K
-19.08%887.52K
-20.86%791.98K
-15.05%4.11M
-13.34%1.1M
Selling and administrative expenses
-45.94%308.99K
-15.30%575.21K
-15.16%574.47K
-24.77%2.21M
-49.78%359.22K
-13.23%571.6K
-20.51%679.08K
1.37%677.09K
-16.57%2.94M
-27.70%715.25K
-Selling and marketing expense
-192.95%-116.37K
-97.38%3.54K
-63.86%116.37K
-51.62%554.56K
-205.14%-347.18K
-55.95%125.19K
-53.87%134.8K
16.10%321.97K
-27.87%1.15M
-17.58%330.21K
-General and administrative expense
-4.71%425.36K
5.03%571.67K
29.00%458.1K
-7.64%1.66M
83.46%706.4K
19.19%446.41K
-3.17%544.27K
-9.10%355.11K
-7.31%1.8M
-34.58%385.04K
Research and development costs
0.75%125.55K
0.62%124.45K
178.37%143.23K
-14.04%586.08K
-42.99%122.31K
-20.00%124.61K
-4.71%123.68K
-74.39%51.45K
-31.50%681.8K
24.86%214.52K
Depreciation amortization depletion
-13.38%7.58K
-13.38%7.58K
-13.38%7.58K
10.95%37.96K
7,087.73%11.72K
1.95%8.75K
-32.01%8.75K
-73.25%8.75K
4.62%34.21K
103.51%163
-Depreciation and amortization
-13.38%7.58K
-13.38%7.58K
-13.38%7.58K
10.95%37.96K
7,087.73%11.72K
1.95%8.75K
-32.01%8.75K
-73.25%8.75K
4.62%34.21K
103.51%163
Provision for doubtful accounts
----
----
----
-60.49%61.75K
----
----
----
----
613.51%156.28K
----
Other operating expenses
-59.34%79.02K
10.68%84.14K
4.14%56.96K
5.99%311.72K
604.10%77.06K
124.12%194.31K
-23.83%76.02K
-43.39%54.7K
13.19%294.09K
-87.52%10.94K
Operating profit
41.57%-487.05K
6.41%-736.3K
2.97%-750.32K
21.80%-3.03M
35.45%-629.96K
4.64%-833.63K
23.28%-786.75K
21.11%-773.29K
15.22%-3.87M
12.74%-975.85K
Net non-operating interest income (expenses)
61.23%-206.94K
67.96%-190.1K
61.40%-176.38K
-69.46%-2.15M
-38.14%-566.04K
-72.10%-533.75K
-96.57%-593.32K
-84.97%-456.9K
-63.16%-1.27M
0.37%-409.74K
Non-operating interest expense
-61.23%206.94K
-67.96%190.1K
-61.40%176.38K
69.46%2.15M
38.14%566.04K
72.10%533.75K
96.57%593.32K
84.97%456.9K
63.16%1.27M
-0.37%409.74K
Other net income (expenses)
17,363.69%594.46K
111.35%3.4K
128.52%8.4K
Gain on sale of security
----
----
----
-198.41%-3.35K
----
----
----
----
151.71%3.4K
274.30%8.4K
Special income (charges)
----
----
----
--597.81K
----
----
----
----
--0
----
-Gain on sale of business
----
----
----
--597.81K
----
----
----
----
--0
----
Income before tax
49.25%-693.99K
32.87%-926.41K
24.67%-926.7K
10.77%-4.58M
56.32%-601.53K
-15.24%-1.37M
-3.62%-1.38M
-0.38%-1.23M
4.41%-5.13M
11.67%-1.38M
Income tax
Earnings from equity interest net of tax
Net income
49.25%-693.99K
32.87%-926.41K
24.67%-926.7K
10.77%-4.58M
56.32%-601.53K
-15.24%-1.37M
-3.62%-1.38M
-0.38%-1.23M
4.41%-5.13M
11.67%-1.38M
Net income continuous operations
49.25%-693.99K
32.87%-926.41K
24.67%-926.7K
10.77%-4.58M
56.32%-601.53K
-15.24%-1.37M
-3.62%-1.38M
-0.38%-1.23M
4.41%-5.13M
11.67%-1.38M
Noncontrolling interests
Net income attributable to the company
49.25%-693.99K
32.87%-926.41K
24.67%-926.7K
10.77%-4.58M
56.58%-601.53K
-14.82%-1.37M
-3.62%-1.38M
-0.38%-1.23M
3.57%-5.13M
8.39%-1.39M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
49.25%-693.99K
32.87%-926.41K
24.67%-926.7K
10.77%-4.58M
56.58%-601.53K
-14.82%-1.37M
-3.62%-1.38M
-0.38%-1.23M
3.57%-5.13M
8.39%-1.39M
Diluted earnings per share
74.30%-0.0026
65.00%-0.0035
64.62%-0.0035
33.33%-0.02
0
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.03
0.00%-0.01
Basic earnings per share
74.30%-0.0026
65.00%-0.0035
64.62%-0.0035
33.33%-0.02
0
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.03
0.00%-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -18.56%90.61K-54.60%104.3K117.05%106.75K-10.68%456.09K-68.83%66.33K23.37%111.26K60.69%229.75K-23.91%49.18K-9.32%510.61K0.02%212.81K
Operating revenue -18.56%90.61K-54.60%104.3K117.05%106.75K-10.68%456.09K-68.83%66.33K23.37%111.26K60.69%229.75K-23.91%49.18K-9.32%510.61K0.02%212.81K
Cost of revenue 23.92%56.53K-61.82%49.24K145.42%74.83K-0.07%270.46K-29.79%64.25K-22.54%45.62K79.83%128.97K-30.86%30.49K-6.59%270.66K40.47%91.51K
Gross profit -48.08%34.08K-45.36%55.07K70.78%31.92K-22.64%185.63K-98.28%2.09K84.49%65.64K41.42%100.78K-8.98%18.69K-12.22%239.95K-17.83%121.3K
Operating expense -42.05%521.13K-10.83%791.37K-1.23%782.24K-21.85%3.21M-42.39%632.05K-1.16%899.27K-19.08%887.52K-20.86%791.98K-15.05%4.11M-13.34%1.1M
Selling and administrative expenses -45.94%308.99K-15.30%575.21K-15.16%574.47K-24.77%2.21M-49.78%359.22K-13.23%571.6K-20.51%679.08K1.37%677.09K-16.57%2.94M-27.70%715.25K
-Selling and marketing expense -192.95%-116.37K-97.38%3.54K-63.86%116.37K-51.62%554.56K-205.14%-347.18K-55.95%125.19K-53.87%134.8K16.10%321.97K-27.87%1.15M-17.58%330.21K
-General and administrative expense -4.71%425.36K5.03%571.67K29.00%458.1K-7.64%1.66M83.46%706.4K19.19%446.41K-3.17%544.27K-9.10%355.11K-7.31%1.8M-34.58%385.04K
Research and development costs 0.75%125.55K0.62%124.45K178.37%143.23K-14.04%586.08K-42.99%122.31K-20.00%124.61K-4.71%123.68K-74.39%51.45K-31.50%681.8K24.86%214.52K
Depreciation amortization depletion -13.38%7.58K-13.38%7.58K-13.38%7.58K10.95%37.96K7,087.73%11.72K1.95%8.75K-32.01%8.75K-73.25%8.75K4.62%34.21K103.51%163
-Depreciation and amortization -13.38%7.58K-13.38%7.58K-13.38%7.58K10.95%37.96K7,087.73%11.72K1.95%8.75K-32.01%8.75K-73.25%8.75K4.62%34.21K103.51%163
Provision for doubtful accounts -------------60.49%61.75K----------------613.51%156.28K----
Other operating expenses -59.34%79.02K10.68%84.14K4.14%56.96K5.99%311.72K604.10%77.06K124.12%194.31K-23.83%76.02K-43.39%54.7K13.19%294.09K-87.52%10.94K
Operating profit 41.57%-487.05K6.41%-736.3K2.97%-750.32K21.80%-3.03M35.45%-629.96K4.64%-833.63K23.28%-786.75K21.11%-773.29K15.22%-3.87M12.74%-975.85K
Net non-operating interest income (expenses) 61.23%-206.94K67.96%-190.1K61.40%-176.38K-69.46%-2.15M-38.14%-566.04K-72.10%-533.75K-96.57%-593.32K-84.97%-456.9K-63.16%-1.27M0.37%-409.74K
Non-operating interest expense -61.23%206.94K-67.96%190.1K-61.40%176.38K69.46%2.15M38.14%566.04K72.10%533.75K96.57%593.32K84.97%456.9K63.16%1.27M-0.37%409.74K
Other net income (expenses) 17,363.69%594.46K111.35%3.4K128.52%8.4K
Gain on sale of security -------------198.41%-3.35K----------------151.71%3.4K274.30%8.4K
Special income (charges) --------------597.81K------------------0----
-Gain on sale of business --------------597.81K------------------0----
Income before tax 49.25%-693.99K32.87%-926.41K24.67%-926.7K10.77%-4.58M56.32%-601.53K-15.24%-1.37M-3.62%-1.38M-0.38%-1.23M4.41%-5.13M11.67%-1.38M
Income tax
Earnings from equity interest net of tax
Net income 49.25%-693.99K32.87%-926.41K24.67%-926.7K10.77%-4.58M56.32%-601.53K-15.24%-1.37M-3.62%-1.38M-0.38%-1.23M4.41%-5.13M11.67%-1.38M
Net income continuous operations 49.25%-693.99K32.87%-926.41K24.67%-926.7K10.77%-4.58M56.32%-601.53K-15.24%-1.37M-3.62%-1.38M-0.38%-1.23M4.41%-5.13M11.67%-1.38M
Noncontrolling interests
Net income attributable to the company 49.25%-693.99K32.87%-926.41K24.67%-926.7K10.77%-4.58M56.58%-601.53K-14.82%-1.37M-3.62%-1.38M-0.38%-1.23M3.57%-5.13M8.39%-1.39M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 49.25%-693.99K32.87%-926.41K24.67%-926.7K10.77%-4.58M56.58%-601.53K-14.82%-1.37M-3.62%-1.38M-0.38%-1.23M3.57%-5.13M8.39%-1.39M
Diluted earnings per share 74.30%-0.002665.00%-0.003564.62%-0.003533.33%-0.0200.00%-0.010.00%-0.010.00%-0.010.00%-0.030.00%-0.01
Basic earnings per share 74.30%-0.002665.00%-0.003564.62%-0.003533.33%-0.0200.00%-0.010.00%-0.010.00%-0.010.00%-0.030.00%-0.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.